EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model

Isaline Louvet, Ana Acosta-Montalvo, Chiara Saponaro, Maria Moreno-Lopez, Sana Douffi, Abdelkrim El Karchaoui, Gianni Pasquetti, Julien Thevenet, Nathalie Delalleau, Valery Gmyr, Paolo Giacobini, Stéphanie Espiard und 4 weitere

JCI Insight · 08.05.2026 · 11 (9)

DOI: 10.1172/jci.insight.198095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 08.05.2026. Verfasst von Isaline Louvet und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, CHU Lille, Inserm U1190, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 1-alpha, Diabetes Mellitus, Type 2. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Foundation for the Study of Diabetes/Novo Nordisk, European Foundation for the Study of Diabetes/Lilly, I-SITE ULNE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HNF1A-MODY, the most common monogenic diabetes, exhibits progressive β cell dysfunction, but existing mouse models fail to recapitulate human disease progression, limiting understanding of pathogenic mechanisms. We developed mice with heterozygous deletion of the Hnf1a transactivation domain ( Hnf1a +/ Δ e4-10 ) to model human HNF1A haploinsufficiency, conducted cross-sectional metabolic characterization, and validated our findings in HNF1A-deficient human islets. Unlike previous models, Hnf1a +/ Δ e4-10 mice successfully recapitulated temporal HNF1A-MODY progression. Male mice developed sequential pathophysiology: early insulin resistance in young adults (7 weeks), followed by testosterone deficiency and fasting hyperglycemia in adult mice (10 weeks). Glucose intolerance emerged in middle-aged mice (30 weeks), progressing to multi-organ dysfunction in aged mice (44–70 weeks), characterized by elevated hepatic gluconeogenesis, impaired renal glucose handling, and hepatic steatosis/fibrosis. This dual pathophysiology involving β cell dysfunction and peripheral insulin resistance was associated with dysregulated hormone secretion from both α and β cells in aged mice (40–70 weeks). Human islet studies with HNF1A knockdown confirmed translational relevance, demonstrating reduced SGLT2 protein expression and inappropriate glucagon and insulin secretion. This work established a physiologically relevant HNF1A-MODY model, identified early insulin resistance as a key mechanism triggering hormonal dysfunction, and revealed HNF1A’s role in multi-organ pathophysiology beyond traditional β cell dysfunction. New mouse model reveals HNF1A-MODY diabetes involves early insulin resistance and testosterone deficiency before β-cell failure, affecting multiple organs beyond the pancreas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 1-alphaDiabetes Mellitus, Type 2AnimalsMiceMaleDisease Models, AnimalHumansInsulin-Secreting CellsInsulin ResistanceDisease ProgressionInsulinGlucose IntoleranceLiver

Stichwörter der Autor:innen

AgingBeta cellsDiabetesEndocrinologyMetabolism

Substanzen

Hepatocyte Nuclear Factor 1-alphaHNF1A protein, humanInsulinHnf1a protein, mouse

Autor:innen und Institutionen

  • University of Lille, CHU Lille, Inserm U1190, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
  • Laboratory of Development and Plasticity of the Neuroendocrine Brain, FHU 1000 Days for Health, School of Medicine, Lille, France.
  • University of Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
  • Department of Pathology, University of Cambridge, Cambridge, United Kingdom.

Förderung

  • European Foundation for the Study of Diabetes/Novo Nordisk
  • European Foundation for the Study of Diabetes/Lilly
  • I-SITE ULNE
  • European Consortium for Islet Transplantation through the Juvenile Diabetes Research Foundation
  • European Genomic Institute for Diabetes

Zitieren

APA

Louvet, I., Acosta-Montalvo, A., Saponaro, C., Moreno-Lopez, M., Douffi, S., El Karchaoui, A., Pasquetti, G., Thevenet, J., Delalleau, N., Gmyr, V., Giacobini, P., Espiard, S., Kerr-Conte, J., Pattou, F., Liston, A., & Bonner, C. (2026). Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model. JCI Insight, 11(9). https://doi.org/10.1172/jci.insight.198095

Vancouver

Louvet I, Acosta-Montalvo A, Saponaro C, Moreno-Lopez M, Douffi S, El Karchaoui A, et al. Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model. JCI Insight. 2026;11(9). doi:10.1172/jci.insight.198095

BibTeX
@article{Louvet2026,
  author = {Louvet, Isaline and Acosta-Montalvo, Ana and Saponaro, Chiara and Moreno-Lopez, Maria and Douffi, Sana and El Karchaoui, Abdelkrim and Pasquetti, Gianni and Thevenet, Julien and Delalleau, Nathalie and Gmyr, Valery and Giacobini, Paolo and Espiard, Stéphanie and Kerr-Conte, Julie and Pattou, François and Liston, Adrian and Bonner, Caroline},
  title = {Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model},
  journal = {JCI Insight},
  year = {2026},
  volume = {11},
  number = {9},
  doi = {10.1172/jci.insight.198095}
}
Kostenlos starten →